Press Releases and Events

PRESS RELEASES

Press Release | July 13, 2025

Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY™ (Paltusotine) in Acromegaly at ENDO 2025

READ MORE
Press Release | July 11, 2025

Crinetics Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 7, 2025

READ MORE
Press Release | July 10, 2025

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | June 30, 2025

Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline

READ MORE
Press Release | June 16, 2025

Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025

READ MORE
Press Release | June 10, 2025

Crinetics Pharmaceuticals Announces June 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | May 23, 2025

Crinetics Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2025

READ MORE
Press Release | May 15, 2025

Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025

READ MORE
Press Release | May 12, 2025

Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | May 8, 2025

Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

READ MORE
4 / 24